SLNO
Soleno Therapeutics Inc
NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY
$52.78
+0.04% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$29 – $90
Volume
3.8M
Soleno Therapeutics Inc (SLNO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $3.00M | $0.00 | $387555.00 | $1.45M | $-1.55B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $190.41M |
| Revenue growth (YoY) | — | — | -100.0% | — | +274.3% | -107145.4% | +100.0% | — | — | — | — | — | — | — |
| Cost of revenue | $3.55M | $3.81M | $0.00 | $352683.00 | $1.51M | $1.61M | $1.92M | $2.30M | $2.19M | $2.21M | $2.21M | $1.96M | $1.99M | $2.70M |
| Gross profit | — | $3.00M | $0.00 | $34872.00 | $-58518.00 | $-1.55B | $-1.92M | $-2.30M | $-2.19M | $-2.21M | $-2.21M | $-1.96M | $-1.99M | $187.71M |
| Gross margin | — | 100.0% | — | 9.0% | -4.0% | 100.1% | — | — | — | — | — | — | — | 98.6% |
| R&D | $2.47M | $2.38M | $2.24M | $4.54M | $5.18M | $3.07M | $7.18M | $16.27M | $23.19M | $21.45M | $15.27M | $25.19M | $78.57M | $40.63M |
| SG&A | $1.13M | $1.47M | $2.67M | $6.14M | $6.74M | $6.58M | $6.56M | $6.93M | $8.76M | $10.81M | $9.84M | $13.48M | $105.86M | $29.26M |
| Operating income | $-3.60M | $-846783.00 | $-5.16M | $-12.16M | $-13.61M | $-12.17M | $-14.30M | $-23.20M | $-31.95M | $-31.53M | $-24.40M | $-41.38M | $-187.67M | $14.95M |
| Operating margin | — | -28.2% | — | -3137.6% | -938.1% | 0.8% | — | — | — | — | — | — | — | 7.9% |
| EBITDA | $-3.57M | $-804857.00 | $-5.13M | $-15.80M | $-6.72M | $-8.07M | $-9.92M | $-28.48M | $-22.45M | $-30.30M | $-22.10M | $-37.03M | $-173.63M | $28.38M |
| EBITDA margin | — | -26.8% | — | -4076.9% | -463.1% | 0.5% | — | — | — | — | — | — | — | 14.9% |
| EBIT | $-3.62M | $-846971.00 | $-5.16M | $-15.91M | $-6.74M | $-9.68M | $-11.84M | $-30.77M | $-24.64M | $-32.26M | $-24.07M | $-38.99M | $-175.62M | $26.37M |
| Interest expense | $2.87M | $2.86M | $4.13M | $3.05M | $0.00 | $0.00 | $62000.00 | $0.00 | $0.00 | $618000.00 | $330000.00 | $0.00 | $231000.00 | $5.48M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.48M | $-3.71M | $-13.87M | $-15.91M | $-12.07M | $-15.67M | $-13.34M | $-30.77M | $-24.64M | $-30.91M | $-24.07M | $-38.99M | $-175.85M | $20.89M |
| Net income growth (YoY) | — | +42.8% | -274.3% | -14.7% | +24.2% | -29.9% | +14.9% | -130.8% | +19.9% | -25.5% | +22.1% | -62.0% | -351.0% | +111.9% |
| Profit margin | — | -123.6% | — | -4104.8% | -831.6% | 1.0% | — | — | — | — | — | — | — | 11.0% |